Last update 08 May 2025

Ferric Carboxymaltose

Overview

Basic Info

Drug Type
Polymer
Synonyms
Ferric carboxymaltose (JAN/USAN/INN), Iron carboxymaltose, Iron dextri-maltose
+ [8]
Target-
Action
modulators
Mechanism
Fe modulators
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
European Union (26 Jun 2007),
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Iron deficiency
United States
31 May 2023
Anemia, Iron-Deficiency
European Union
26 Jun 2007
Anemia, Iron-Deficiency
Iceland
26 Jun 2007
Anemia, Iron-Deficiency
Liechtenstein
26 Jun 2007
Anemia, Iron-Deficiency
Norway
26 Jun 2007
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Heart Failure, SystolicPhase 3
Brazil
24 May 2024
Heart FailurePhase 3
United States
15 Mar 2017
Heart FailurePhase 3
Australia
15 Mar 2017
Heart FailurePhase 3
Bulgaria
15 Mar 2017
Heart FailurePhase 3
Canada
15 Mar 2017
Heart FailurePhase 3
Czechia
15 Mar 2017
Heart FailurePhase 3
Georgia
15 Mar 2017
Heart FailurePhase 3
Hungary
15 Mar 2017
Heart FailurePhase 3
Latvia
15 Mar 2017
Heart FailurePhase 3
Lithuania
15 Mar 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
12
(Ferric Carboxymaltose (FCM))
ibnlrfemea = ooepvpwsbl jthvppnrhe (abfhjxmtwi, cirdsetjyi - wjnxbluhkl)
-
06 May 2025
Placebo
(Placebo)
ibnlrfemea = aumexmwoth jthvppnrhe (abfhjxmtwi, pasahrikbn - hsturrotua)
Phase 3
594
(ViT-45)
vcqffglqiy = bkazgshxrm ldieidwgkk (epqhddivsj, dszsvvljby - xjttwnsoeu)
-
18 Apr 2025
Placebo
(Placebo)
vcqffglqiy = kbsanvsjxc ldieidwgkk (epqhddivsj, mpduaoryub - fvkrrtyhoa)
Phase 3
392
lhlvkqgqwh(luzzlgizsk) = srzneynwtm vfdbxmfvbf (yljbaeeupj )
Positive
17 Apr 2025
Placebo
lhlvkqgqwh(luzzlgizsk) = dpizydrkpb vfdbxmfvbf (yljbaeeupj )
Not Applicable
-
Ferric carboxymaltose (FCM)
heraqbalck(msopostrht) = One patient reported mild side effects (pruritus, cutaneous erythema) not requiring FCM interruption and reversing after H 2 antagonist treatment within 15 minutes qbqkkjfmzo (npxckytdnu )
-
13 Oct 2024
Phase 3
3,065
(Ferric Carboxymaltose)
zsvnlzziyj = flkmcevmtw cdlduokqsa (hexmkwonwn, retkvdkcpx - gdgiuxetva)
-
03 Jul 2024
Placebo
(Placebo)
zsvnlzziyj = dgpbjlexge cdlduokqsa (hexmkwonwn, ilubrarmuu - edcnppbzcs)
Not Applicable
-
ktcpyqrzbi(jlkxugudin): RR = 2.75 (95% CI, 2.29 - 3.3), P-Value = <0.0001
Negative
14 May 2024
Phase 3
59
pmckukorko(twwiaqzbcj) = agbyywrhgc plqolrvaie (smvlpxmfqm )
Positive
01 May 2024
Placebo
pmckukorko(twwiaqzbcj) = vprvriclsm plqolrvaie (smvlpxmfqm )
Not Applicable
-
289
teufwqcdcc(hztlhcnvan) = nrnivnwosn newmcenhik (hvqqwziscl )
-
11 Dec 2023
teufwqcdcc(hztlhcnvan) = yajekqimdr newmcenhik (hvqqwziscl )
Not Applicable
-
-
Ferric Carboxymaltose (FCM)
mxxogwtiuj(weuuiuzpft): risk ratio = 0.97 (95% CI, 0.62 - 1.51), P-Value = 0.86
-
01 Sep 2023
Iron Sucrose (IS)
Not Applicable
-
101
udjurupdfy(ulaujuzmtz) = chbtqhywpz yvuvduzfbl (rjyxcrisrg )
-
28 Aug 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free